PRENW NASDAQ
Credit Risk of going bust: lower than 67% of companies Debt: 0.2% of company value Bonds: none of note held by US funds details ▾
Total debt $682K against a stock market value of $312.2M.
Distance to default 7.12 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $538K (short-term plus half of long-term), stock volatility 85.0%; Altman Z'' 3.44. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Hong Kong
HK
Prenetics Global Limited operates as an investment holding company specializing in diagnostics and genetic testing. Its core offerings include CircleDNA, a consumer genetic testing solution, and the Circle HealthPod, a rapid detection health monitoring system that enables users to perform point-of-care or at-home COVID-19 tests using nucleic acid amplification technology. The company's portfolio further comprises ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an accessible at-home blood testing kit; and Circle Medical, a diagnostic testing platform. Other products include Circle One, F1x, and Fem. Established in 2014, Prenetics Global Limited is headquartered in Quarry Bay, Hong Kong.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Shah Darshan Ravindr | 0 | — | 2026-03-26 | |
| Shah Darshan Ravindr | 5,599 | — | 2026-03-26 | |
| Yeung Danny Sheng Wu | 0 | — | 2026-03-26 | |
| Yeung Danny Sheng Wu | 0 | — | 2026-03-26 | |
| Yeung Danny Sheng Wu | 0 | — | 2026-03-26 |